Learn More
Medchemexpress LLC Velagliflozin proline | 1539295-26-5 | 99.4% | 510.58 | 1 ML

Supplier: Medchemexpress LLC HY109018A10MM/1ML
Velagliflozin proline is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor that exhibits antidiabetic activity. It functions by decreasing renal glucose reabsorption and promoting glycosuria, which consequently leads to a reduction in blood sugar and insulin concentrations.
- Increases cholesterol, albumin, beta-hydroxybutyrate, nonesterified fatty acids, and urinary glucose excretion.
- Decreases respiratory exchange ratio.
- Is well tolerated.
- Can improve insulin disorders.
- Prevents laminitis by reducing the high insulin response of dietary non-structural carbohydrates.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.